Diprosone and Oxycodone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Diprosone (betamethasone dipropionate) and Oxycodone (oxycodone hydrochloride). Common drug interactions include anaemia among females and arthralgia among males.

The phase IV clinical study analyzes what interactions people have when they take Diprosone and Oxycodone. It is created by eHealthMe based on reports of 37 people who take the same drugs from the FDA, and is updated regularly.

What is Diprosone?

Diprosone has active ingredients of betamethasone dipropionate. eHealthMe is studying from 2,045 Diprosone users. Check the latest studies of Diprosone.

What is Oxycodone?

Oxycodone has active ingredients of oxycodone hydrochloride. It is often used in pain. eHealthMe is studying from 162,592 Oxycodone users. Check the latest studies of Oxycodone.



On Aug, 08, 2026

37 people who take Diprosone and Oxycodone together, and have interactions are studied.

Diprosone and Oxycodone drug interactions.

What are the common drug interactions of Diprosone and Oxycodone, by gender? *:

female:

  1. Anaemia (lack of blood)
  2. Lung neoplasm (tumour of lung)
  3. Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
  4. Sepsis (a severe blood infection that can lead to organ failure and death)
  5. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  6. Cellulitis (infection under the skin)
  7. Fall
  8. Localised infection (infection at the single location)
  9. Skin disorder (skin disease)
  10. Wound infection

male:

  1. Arthralgia (joint pain)
  2. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  3. Inflammatory pain
  4. Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
  5. General physical health deterioration (weak health status)
  6. Multi-organ failure (multisystem organ failure)
  7. Renal failure (kidney dysfunction)
  8. Chest pain
  9. Erythema (redness of the skin)
  10. Malignant neoplasm progression (cancer tumour came back)

What are the common drug interactions of Diprosone and Oxycodone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Arthralgia (joint pain)
  2. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  3. Haematochezia (passage of stools containing blood)
  4. Nausea (feeling of having an urge to vomit)
  5. Osteopenia (a condition where bone mineral density is lower than normal)
  6. Pancreatitis (inflammation of pancreas)
  7. Plantar fasciitis (painful inflammatory process of the plantar fascia)
  8. Psoriasis (immune-mediated disease that affects the skin)
  9. Renal impairment (severely reduced kidney function)
  10. Secondary hypogonadism (a male refers to a decrease in either of the two major functions of the testes: sperm production or testosterone production)

60+:

  1. Anaemia (lack of blood)
  2. Lung neoplasm (tumour of lung)
  3. Coma (state of unconsciousness lasting more than six hours)
  4. Erythema (redness of the skin)
  5. Hypertension (high blood pressure)
  6. Joint stiffness
  7. Joint swelling
  8. Local swelling (swelling at the site of some application of substance or injury)
  9. Malignant neoplasm progression (cancer tumour came back)
  10. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 9 people, 24.32%
  2. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 9 people, 24.32%
  3. High Blood Pressure: 5 people, 13.51%
  4. Itching: 3 people, 8.11%
  5. Nausea (feeling of having an urge to vomit): 3 people, 8.11%
  6. Hypokalemia (low potassium): 3 people, 8.11%
  7. Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood): 2 people, 5.41%
  8. Abdominal Pain Upper: 2 people, 5.41%
  9. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 2 people, 5.41%
  10. Cellulitis (infection under the skin): 2 people, 5.41%

* Approximation only. Some reports may have incomplete information.

Do you take Diprosone and Oxycodone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Diprosone and Oxycodone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Diprosone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Oxycodone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Diprosone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Oxycodone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on betamethasone dipropionate and oxycodone hydrochloride (the active ingredients of Diprosone and Oxycodone, respectively), and Diprosone and Oxycodone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: